4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001193125-26-257564
Options or other derivatives
- Director acquired 9,000 shares (grant or award)
From the SEC's structured data for this filing
Kalaris Therapeutics, Inc. Filed Acc 0001193125-26-257564
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…